Market Analysis: Anesthesia

The worldwide market for anesthesia and respiratory devices could exceed $14 billion by 2017, at a 4.7 percent compound annual growth rate (CAGR), pushed along by “the huge patient population suffering from respiratory diseases such as chronic obstructive pulmonary disease (COPD) and the availability of medical devices to treat obstructive sleep apnea and COPD,” according to a report from ASD media.

The numbers of those suffering from such diseases are staggering, ASD notes: 300 million people are battling OSA, including as many as 30 to 80 percent of seniors. Anywhere from 400 to 600 million people are stricken with COPD, at least 12 million of whom are Americans.

Those figures alone would provide ample evidence for growth in the market. Growth is further accentuated by the prevalence of such devices in new hospitals and health centers, as well as in the home healthcare market.

Managing those devices from a centralized location also helps drive efficiencies in data, patient safety and the allocation of services institution-wide, which ASD forecasts “will result in an increase in the adoption rate of anesthesia and respiratory care devices, leading to a growth of the market.”

Contributing to that growth will be the further automation of patient medical records, ASD reports, which will necessarily be integrated within devices as they become “smarter” and further connected to a seamless network of health information.

Read more in the Feb. 2013 issue of Medical Dealer Magazine.